Increased serum lipoprotein(a) concentrations after growth hormone (GH) treatment in patients with isolated GH deficiency

Annals of Clinical Biochemistry

Volumn 33, Issue 4, 1996, Pages 330-334

  O'Halloran, Domhnall J ^a   Wieringa, Gilbert ^a   Tsatsoulis, Agathocles ^a   Shalet, Stephen M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Glucose; Glycosylated Hb; Lipid fractions; Weight

Indexed keywords

GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN GROWTH HORMONE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ADULTHOOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029922627     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329603300408     Document Type: Article

References (20)

1. Rosen T, Bengtsson B-A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-8
2. Scott J. Lipoprotein(a). BMJ 1991; 303: 663-4
3. Scanu AM. Lipoprotein(a). A genetic risk factor for premature coronary heart disease. JAMA 1992; 267: 3326-9
4. Utermann G. The mysteries of lipoprotein(a). Science 1989; 246: 904-10
5. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989; 321: 1797-803
6. Eden S, Wiklund O, Oscarsson J, Rosen T, Bengtsson B-A. Growth hormone treatment of growth hormone-deficiency adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscl Thromb 1993; 13: 296-301
7. White RM, Scheafer EJ, Papadopoulos NM. The effect of growth hormone administration on lipids and lipoproteins in growth hormone-deficiency patients. Proc R Soc Med 1983; 173: 63-7
8. Keller U, Miles JM. Growth hormone and lipids. Horm Res 1991; 36(suppl.1): 36-40
9. Merimee TJ. Familial combined hyperlipidaemia. J Clin Invest 1980; 65: 829-35
10. Olivecrona H, Ericson S, Berglund L, Angelin B. Increased concentrations of serum lipoprotein(a) in response to growth hormone treatment. BMJ 1993; 306: 1726-7
11. Aloia JF, Zanzi I, Cohn SH. Absence of an effect of chronic administration of growth hormone on serum lipids. Metabolism 1975; 7: 795-8
12. Hintz RL, Wilson DM, Finno J, Rosenfield RG, Bennett A, McClellan B. Biosynthetic methionyl growth hormone is biologically active in the adult man. Lancet 1982; i: 1276-9
13. Snyder DK, Clemmons DR, Underwood LE. Treatment of obese, diet restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis and body composition. J Clin Endocrinol Metabol 1988; 67: 54-61
14. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM. Increased bone mineral density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metabol 1993; 76: 1344-8
15. Friedewald WT, Levy RL, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
16. Lindahl G, Gersdorf E, Menzel HJ, Seed M, Humphries SE, Utermann G. Variation in the size of human apolipoprotein(a) is due to a hypervariable region in the gene. Hum Genet 1990; 84(6): 563-8
17. Hoffman SL, Eaton DL, Brown MS, McConathy WJ, Goldstein JL, Hammer RE. Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J Clin Invest 1990; 85: 1542-7
18. Rudling M, Norstedt G, Olivecrona H, Reihner E, Gustafsson J-A, Angelin B. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA 1992; 89: 6983-7
19. Kostner GM, Gavish D, Leopold B, Bolzano K, Weintraub MS, Breslow JL. HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation 1989; 80: 1313-9
20. Garber AM, Avins AL. Triglyceride concentration and coronary heart disease. BMJ 1994; 309: 2-3